ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.20
      0.91%
      US Tech 100
      17,178.00
      1.88%
      Dow Jones
      38,225.66
      0.85%
      Brent Oil
      83.805
      0.21%
      Bitcoin
      59,615.80
      0.83%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ)

      7. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ) News

      LGNZZ

      Ligand Pharmaceuticals (PK) (LGNZZ)

      Ligand Pharmaceuticals Incorporated (PK)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:LGNZZ
      DateTimeSourceHeadlineSymbolCompany
      2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      06/05/20204:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      05/08/20204:29PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      05/06/20204:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/24/20207:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/24/20207:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/24/20207:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/24/20204:10PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/24/20204:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/07/20204:41PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/06/20205:16PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      04/02/20204:19PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      03/13/20206:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/27/20205:38PMEdgar (US Regulatory)Annual Report (10-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/18/20205:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/18/20205:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/18/20205:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/18/20205:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/14/20201:19PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/14/202011:34AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/14/202010:04AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/14/20207:45AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/13/202011:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/12/20208:10AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/11/20204:28PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/10/202012:03PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/10/20207:34AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      02/06/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      01/10/20205:10PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
      01/10/20201:55PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
       Showing the most relevant articles for your search:USOTC:LGNZZ